Patient 2 with decompensated cirrhosis due to alcohol with short duration of sobriety
Christina C. Lindenmeyer, Nicole Welch, William D. Carey – 26 July 2018
Christina C. Lindenmeyer, Nicole Welch, William D. Carey – 26 July 2018
Saad Saffo, Tamar Taddei – 26 July 2018
Yuval A. Patel, Kara Wegermann, Carl L. Berg, Lindsay Y. King – 26 July 2018
Yuval A. Patel, Kara Wegermann, Carl L. Berg, Lindsay Y. King – 26 July 2018
Saad Saffo, Tamar Taddei – 26 July 2018
Mina Rakoski, Preeya Goyal, Michelle Spencer‐Safier, Jill Weissman, Gina Mohr, Michael Volk – 26 July 2018
Álvaro Díaz‐González, Ester Monclús, Anna Darnell, Manel Solé, Jordi Bruix – 25 July 2018
Álvaro Díaz‐González, Ester Monclús, Anna Darnell, Manel Solé, Jordi Bruix – 25 July 2018
Cristina Margini, Giuseppe Murgia, Guido Stirnimann, Andrea De Gottardi, Nasser Semmo, Stefania Casu, Jaime Bosch, Jean‐François Dufour, Annalisa Berzigotti – 24 July 2018 – Obesity and steatosis have been associated with liver disease progression in patients with compensated advanced chronic liver disease (cACLD) (liver stiffness measurement [LSM] ≥ 10 kPa). The controlled attenuation parameter (CAP) estimates steatosis during LSM by transient elastography. We aimed to evaluate whether CAP is associated with the development of clinically relevant events in cACLD.